Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transoral Robotic Surgery-Based Treatment Versus Definitive Chemoradiation for Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Head & neck·2026
Same author

A Standardized Algorithm's Impact on Primary Detection in Head and Neck Carcinoma of Unknown Primary.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same author

Functional impact of transoral surgery and risk-based adjuvant therapy in human papillomavirus-associated oropharyngeal cancer: swallowing outcomes from ECOG-ACRIN E3311.

JCO oncology advances·2026
Same author

Neoadjuvant Chemoimmunotherapy in Resectable Head and Neck Cancers-Is It the Way Forward?

JAMA otolaryngology-- head & neck surgery·2026
Same author

Cancer cell identification in tissue imaging via phasor map analysis in polarization-resolved two-photon excitation fluorescence microscopy.

Biomedical optics express·2026
Same author

Treatment of P16-Negative/HPV-Negative Oropharyngeal Squamous Cell Carcinoma: A Survey of AHNS Membership.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026

Related Experiment Video

Updated: Apr 11, 2026

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy
05:25

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy

Published on: October 24, 2025

863

Transoral robotic retropharyngeal node dissection.

Babak Givi1, Scott H Troob2, Will Stott2

  • 1Department of Otolaryngology-Head and Neck Surgery, New York University, New York, New York.

Head & Neck
|June 5, 2015
PubMed
Summary
This summary is machine-generated.

Transoral robotic surgery (TORS) provides feasible access to retropharyngeal lymph nodes (RPLNs). While well-tolerated for papillary thyroid cancer, TORS increases complication risks for oropharyngeal squamous cell carcinoma patients.

Keywords:
lymph node dissectionoropharynx neoplasmpapillary thyroid cancerretropharyngeal spacetransoral robotic surgery

More Related Videos

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
04:01

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

1.8K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

7.0K

Related Experiment Videos

Last Updated: Apr 11, 2026

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy
05:25

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy

Published on: October 24, 2025

863
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
04:01

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

1.8K
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

7.0K

Area of Science:

  • Head and Neck Surgery
  • Robotic Surgery
  • Surgical Oncology

Background:

  • Surgical access to retropharyngeal lymph nodes (RPLNs) can be challenging.
  • Transoral robotic surgery (TORS) offers a potential solution for RPLN dissection.
  • This study evaluates the feasibility and outcomes of TORS for RPLN metastases.

Purpose of the Study:

  • To describe and evaluate the transoral robotic surgery (TORS) approach for retropharyngeal lymph node (RPLN) dissection.
  • To assess the safety and efficacy of TORS in managing RPLN metastases.

Main Methods:

  • A case series of patients undergoing TORS for RPLN dissection was conducted.
  • Patients were compared to matched controls in a 1:2 ratio.
  • Data collected included patient demographics, pathology, operative outcomes, and complications.

Main Results:

  • Twelve patients underwent robotic RPLN dissection for oropharyngeal squamous cell carcinoma (SCC) or papillary thyroid cancer (PTC).
  • Average feeding tube dependence was 12 days, with no significant difference compared to controls.
  • Complication rates were higher in patients with oropharyngeal SCC.

Conclusions:

  • Transoral robotic surgery (TORS) is a feasible technique for accessing retropharyngeal lymph nodes (RPLNs).
  • TORS is well-tolerated in patients with papillary thyroid cancer (PTC).
  • Patients with oropharyngeal squamous cell carcinoma (SCC) face an increased risk of complications with TORS.